The U.S. Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in adult patients, aged 55 years and older, exhibiting signs and...
What is it prescribed for? GOMEKLI is prescribed for adults and children 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that cannot be completely removed by surgery​. What is the name of the drug and what does it do? The brand name is GOMEKLI (pronounced "go-MEK-lee"), and the generic name is mirdametinib....
GLP-1 medications like semaglutide (Ozempic/Wegovy), liraglutide, dulaglutide, and others have become some of the most popular treatments for type 2 diabetes and weight loss. Millions of people now use these medicines every month. Because so many adults are starting GLP-1 drugs, it is more important than ever to understand their possible risks and side effects, not...
A Simple Nasal Spray Being Tested for More Than Allergies Scientists have recently become interested in a common nasal spray used for allergies because early lab studies showed that it might also help stop viruses, including the virus that causes COVID-19, from entering the body.A new clinical trial published in JAMA Internal Medicine tested whether Azelastine nasal...
Semaglutide — best known as the key ingredient in Ozempic and Wegovy — may be doing more than helping people lose weight. In this video, we dive into new research exploring semaglutide’s unexpected effects on heart health. You’ll hear about a major 2025 study that tested how the drug impacted heart failure symptoms and physical function — and what these findings could mean for people living with obesity and heart conditions.
A new study published in The Lancet evaluated whether semaglutide—the active ingredient in Ozempic and Wegovy—may help more than just weight loss. Researchers found that weekly injections of semaglutide improved heart failure symptoms, physical function, and quality of life in people living with a combination of heart failure and obesity. Why Researchers Are...